ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.


Player Avatar pchop123 (80.21) Submitted: 1/7/2013 2:11:43 PM : Underperform Start Price: $4.85 ACAD Score: -14.09

What goes up fast can come down even faster

Featured Broker Partners